Evidence map›Paper›PMID 37831716›Full record

Observational studyPLoS medicine2023

Risk factors for extended-spectrum beta-lactamase (ESBL)-producing E. coli carriage among children in a food animal-producing region of Ecuador: A repeated measures observational study.

Heather K Amato, Fernanda Loayza, Liseth Salinas, Diana Paredes, Daniela Garcia, Soledad Sarzosa, Carlos Saraiva-Garcia, Timothy J Johnson, Amy J Pickering, Lee W Riley and 2 more

Open access · goldAbstract readObservational Study
In one paragraph

Observational study in PLoS medicine, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 15 papers.

0numbers the graph read from it
0cells of the map it votes in
15citing papers in PubMed
1.2field-weighted citation impact, top 22% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

15 citing papers in PubMed, 13 citations in OpenAlex.

  1. Review
  2. Article
  3. Article
  4. Genomic Diversity and Extended-SpectrumInternational journal of microbiology · 2026
    Article
  5. Article
  6. Veterinary and animal science · 2025
    Article
  7. Article
  8. Article
  9. Environmental Exposures and the Human Gut Resistome in Northwest Ecuador.medRxiv : the preprint server for health sciences · 2025
    Article
  10. Article
  11. Article
  12. Detection of mobile colistin resistance genesMicrobiology resource announcements · 2024
    Article
  13. Detecting Class 1 Integrons and Their Variable Regions inAntibiotics (Basel, Switzerland) · 2024
    Article
  14. Observational
  15. Genomic insights into ESBL-producingFrontiers in veterinary science · 2023
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors at 3 institutions in 2 countries.

Heather K AmatoEnvironmental Health Sciences Division, School of Public Health, University of California, Berkeley, California, United States of America.ORCID 0000-0002-0501-0756
Fernanda LoayzaInstituto de Microbiología, Colegio de Ciencias Biológicas y Ambientales, Universidad San Francisco de Quito, Quito, Ecuador.ORCID 0000-0002-7629-4864
Liseth SalinasInstituto de Microbiología, Colegio de Ciencias Biológicas y Ambientales, Universidad San Francisco de Quito, Quito, Ecuador.ORCID 0000-0001-6319-3012
Diana ParedesInstituto de Microbiología, Colegio de Ciencias Biológicas y Ambientales, Universidad San Francisco de Quito, Quito, Ecuador.ORCID 0000-0001-9211-4918
Daniela GarciaInstituto de Microbiología, Colegio de Ciencias Biológicas y Ambientales, Universidad San Francisco de Quito, Quito, Ecuador.ORCID 0000-0002-2391-3043
Soledad SarzosaInstituto de Microbiología, Colegio de Ciencias Biológicas y Ambientales, Universidad San Francisco de Quito, Quito, Ecuador.
Carlos Saraiva-GarciaInstituto de Microbiología, Colegio de Ciencias Biológicas y Ambientales, Universidad San Francisco de Quito, Quito, Ecuador.ORCID 0000-0003-0224-9734
Timothy J JohnsonDepartment of Veterinary and Biomedical Sciences, University of Minnesota, Saint Paul, Minnesota, United States of America.
Amy J PickeringDepartment of Civil and Environmental Engineering, University of California, Berkeley, California, United States of America.ORCID 0000-0001-6193-2221
Lee W RileyDivision of Infectious Diseases and Vaccinology, School of Public Health, University of California, Berkeley, California, United States of America.
Gabriel TruebaInstituto de Microbiología, Colegio de Ciencias Biológicas y Ambientales, Universidad San Francisco de Quito, Quito, Ecuador.
Jay P GrahamEnvironmental Health Sciences Division, School of Public Health, University of California, Berkeley, California, United States of America.ORCID 0000-0001-7062-6293
Universidad San Francisco de Quito · ECUniversity of California, Berkeley · USUniversity of Minnesota · US

Funding

Antimicrobial Resistance Transmission Associated with Small-Scale Food-Animal Production in Peri-Urban Communities of Quito, EcuadorR01AI135118 · NIAID · UNIVERSITY OF CALIFORNIA BERKELEY · PI GRAHAM, JAY PAUL · 2018 to 2021
$2.0M
NIAID NIH HHS R01 AI135118
6 · The paper itself

Abstract

backgroundThe spread of antibiotic-resistant bacteria may be driven by human-animal-environment interactions, especially in regions with limited restrictions on antibiotic use, widespread food animal production, and free-roaming domestic animals. In this study, we aimed to identify risk factors related to commercial food animal production, small-scale or "backyard" food animal production, domestic animal ownership, and practices related to animal handling, waste disposal, and antibiotic use in Ecuadorian communities. METHODS AND

findingsWe conducted a repeated measures study from 2018 to 2021 in 7 semirural parishes of Quito, Ecuador to identify determinants of third-generation cephalosporin-resistant E. coli (3GCR-EC) and extended-spectrum beta-lactamase E. coli (ESBL-EC) in children. We collected 1,699 fecal samples from 600 children and 1,871 domestic animal fecal samples from 376 of the same households at up to 5 time points per household over the 3-year study period. We used multivariable log-binomial regression models to estimate relative risks (RR) of 3GCR-EC and ESBL-EC carriage, adjusting for child sex and age, caregiver education, household wealth, and recent child antibiotic use. Risk factors for 3GCR-EC included living within 5 km of more than 5 commercial food animal operations (RR: 1.26; 95% confidence interval (CI): 1.10, 1.45; p-value: 0.001), household pig ownership (RR: 1.23; 95% CI: 1.02, 1.48; p-value: 0.030) and child pet contact (RR: 1.23; 95% CI: 1.09, 1.39; p-value: 0.001). Risk factors for ESBL-EC were dog ownership (RR: 1.35; 95% CI: 1.00, 1.83; p-value: 0.053), child pet contact (RR: 1.54; 95% CI: 1.10, 2.16; p-value: 0.012), and placing animal feces on household land/crops (RR: 1.63; 95% CI: 1.09, 2.46; p-value: 0.019). The primary limitations of this study are the use of proxy and self-reported exposure measures and the use of a single beta-lactamase drug (ceftazidime with clavulanic acid) in combination disk diffusion tests for ESBL confirmation, potentially underestimating phenotypic ESBL production among cephalosporin-resistant E. coli isolates. To improve ESBL determination, it is recommended to use 2 combination disk diffusion tests (ceftazidime with clavulanic acid and cefotaxime with clavulanic acid) for ESBL confirmatory testing. Future studies should also characterize transmission pathways by assessing antibiotic resistance in commercial food animals and environmental reservoirs.

conclusionsIn this study, we observed an increase in enteric colonization of antibiotic-resistant bacteria among children with exposures to domestic animals and their waste in the household environment and children living in areas with a higher density of commercial food animal production operations.

Indexed as

CeftazidimeEscherichia coliAnimalsAnti-Bacterial AgentsBacteriabeta-LactamasesCephalosporinsChildClavulanic AcidDogsEcuadorFemaleHumansMaleRisk FactorsSwineAnti-Bacterial Agentsbeta-LactamasesCeftazidimeCephalosporinsClavulanic Acid

Identifiers

PMID37831716
PMCPMC10621961
OpenAlexW4387611595

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.